Real-time enrollment status for this adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:57 PM UTC
| NCT Number | NCT07259317 |
| Recruiting Status | Recruiting |
| Condition | Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 80 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Corcept Therapeutics |
| Last Updated on CT.gov | September 25, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT07259317 is currently recruiting participants. This phase2 study for adenocarcinoma is actively seeking new participants at 20 locations across the United States. The study is sponsored by Corcept Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07259317 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07259317 was last updated 2 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.